Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
Calabretta E, Moraleda JM, Iacobelli M, Jara R, Vlodavsky I, O'Gorman P, Pagliuca A, Mo C, Baron RM, Aghemo A, Soiffer R, Fareed J, Carlo-Stella C, Richardson P. Calabretta E, et al. Among authors: vlodavsky i. Br J Haematol. 2021 Apr;193(1):43-51. doi: 10.1111/bjh.17240. Epub 2021 Feb 4. Br J Haematol. 2021. PMID: 33538335 Free PMC article. No abstract available.
Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?".
Richardson E, Carlo-Stella C, Jara R, Vlodavsky I, Iacobelli M, Fareed J, Mo C, O'Gorman P, Yanik G, Palomo M, Diaz-Ricart M, Moraleda JM; DEFACOVID Study Group. Richardson E, et al. Among authors: vlodavsky i. J Thromb Haemost. 2020 Nov;18(11):3111-3113. doi: 10.1111/jth.15088. J Thromb Haemost. 2020. PMID: 32860297 Free PMC article. No abstract available.
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.
Richardson E, García-Bernal D, Calabretta E, Jara R, Palomo M, Baron RM, Yanik G, Fareed J, Vlodavsky I, Iacobelli M, Díaz-Ricart M, Richardson PG, Carlo-Stella C, Moraleda JM. Richardson E, et al. Among authors: vlodavsky i. Expert Opin Ther Targets. 2021 Jun;25(6):423-433. doi: 10.1080/14728222.2021.1944101. Epub 2021 Jun 25. Expert Opin Ther Targets. 2021. PMID: 34167431 Review.
The potential of heparanase as a therapeutic target in cancer.
Pisano C, Vlodavsky I, Ilan N, Zunino F. Pisano C, et al. Among authors: vlodavsky i. Biochem Pharmacol. 2014 May 1;89(1):12-9. doi: 10.1016/j.bcp.2014.02.010. Epub 2014 Feb 22. Biochem Pharmacol. 2014. PMID: 24565907 Free PMC article.
Heparanase-The Message Comes in Different Flavors.
Ilan N, Bhattacharya U, Barash U, Boyango I, Yanku Y, Gross-Cohen M, Vlodavsky I. Ilan N, et al. Among authors: vlodavsky i. Adv Exp Med Biol. 2020;1221:253-283. doi: 10.1007/978-3-030-34521-1_9. Adv Exp Med Biol. 2020. PMID: 32274713 Review.
519 results